Please enter a valid month/year e.g. 01/2015

Pick a date between March 2000 and November 2022

Showing 1 to 10 of 454
Title Type Anticipated publication date
Axitinib, everolimus, sorafenib and sunitinib for treated advanced or metastatic renal cell carcinoma [ID897] Technology appraisal guidance Anticipated publication date:TBC 0
Ab interno supraciliary microstent insertion with phacoemulsification for primary open-angle glaucoma Interventional procedures guidance Anticipated publication date:TBC 0
Abatacept for treating active psoriatic arthritis after DMARDs [ID993] Technology appraisal guidance Anticipated publication date:25 July 2018 20180725
Abdominal aortic aneurysm: diagnosis and management NICE guideline Anticipated publication date:07 November 2018 20181107
Abemaciclib monotherapy for treating advanced hormone-receptor positive, HER2-negative breast cancer after endocrine therapy and chemotherapy ID1347 Technology appraisal guidance Anticipated publication date:TBC 0
Abemaciclib with an aromatase inhibitor for untreated advanced hormone-receptor positive, HER2-negative breast cancer ID1227 Technology appraisal guidance Anticipated publication date:TBC 0
Abemaciclib with fulvestrant for treating advanced hormone-receptor positive, HER2-negative breast cancer after endocrine therapy ID1339 Technology appraisal guidance Anticipated publication date:TBC 0
Abiraterone for the treatment of metastatic, castrate-resistant prostate cancer following previous cytotoxic chemotherapy TA259 Technology appraisal guidance Anticipated publication date:TBC 0
Abiraterone for treating newly diagnosed metastatic hormone-naive prostate cancer [ID945] Technology appraisal guidance Anticipated publication date:26 September 2018 20180926
Acute coronary syndromes NICE guideline Anticipated publication date:07 May 2020 20200507